Zhu Jin-Hui, Wang Yue-Dong, Ye Zai-Yuan, Zhao Ting, Zhu Yang-Wen, Xie Zhi-Jie, Liu Jin-Ming
Department of Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Hangzhou, China.
Surg Laparosc Endosc Percutan Tech. 2009 Jun;19(3):258-62. doi: 10.1097/SLE.0b013e3181a6ec7c.
Since the first laparoscopic splenectomy (LS) in 1991, LS has become the gold standard for the removal of normal-to-moderately enlarged spleens in benign conditions. Compared with open splenectomy (OS), fewer postsurgical complications and better postoperative recovery were observed, but it is contraindicated for hypersplenism secondary to liver cirrhosis owing to technical difficulties associated with splenomegaly, well-developed collateral circulation, and increased risk of bleeding. With the improvements of laparoscopic technique, the concept is changing.
OS and LS performed for hypersplenism secondary to liver cirrhosis at our institution were analyzed. Relationships between postoperative increases in platelet counts, white blood cell counts, hemoglobin, and liver function were examined. Perioperative data of LSs were compared with those of OSs, including operative time, blood loss, excised spleen weight, complications, and hospital stays.
A total of 216 splenectomies (135 OS and 81 LS) were performed from April 1999 to March 2007. Five laparoscopic cases were converted to open surgery owing to operative bleeding or bleeding of splenic fossa. The other 76 patients were performed LSs successfully. No major operative complications occurred. There was no operative death. Excised spleen weight >400 g was present in 56% of cases in this series. At 7 days postoperatively, the platelet counts, white blood cell counts, and hemoglobin significantly increased after open and laparoscopic surgeries, and increase of alanine aminotransferase, aspartate aminotransferase, total bilirubin, and directed bilirubin of LS were significantly different with open cases. Operation times of LS and OS were 2.9+/-0.7 hours and 2.6+/-0.6 hours, respectively. Blood losses were 150.6+/-135.4 mL and 633.8+/-340.3 mL (P<0.01), excised spleen weights were 585.7+/-184.6 g and 591.1+/-153.4 g (P>0.05), and hospital stay were 8.2+/-2.0 days and 11.9+/-3.8 days (P<0.01). Operative associated complications were noted in both LS and OS. Less blood loss, shorter hospital stay, and less impairment of liver function were observed in LS than OS.
LS is feasible, effective, and safe procedures for hypersplenism secondary to liver cirrhosis and contributes to less impairment of liver function, less blood loss, and shorter hospital stay.
自1991年首例腹腔镜脾切除术(LS)开展以来,LS已成为良性疾病中切除正常至中度肿大脾脏的金标准。与开放性脾切除术(OS)相比,观察到术后并发症更少且术后恢复更好,但由于脾肿大、侧支循环发达及出血风险增加导致的技术困难,LS对肝硬化继发的脾功能亢进为禁忌。随着腹腔镜技术的改进,这一观念正在改变。
分析了我院因肝硬化继发脾功能亢进而实施的OS和LS。检查术后血小板计数、白细胞计数、血红蛋白及肝功能升高之间的关系。将LS的围手术期数据与OS的进行比较,包括手术时间、失血量、切除脾脏重量、并发症及住院时间。
1999年4月至2007年3月共实施了216例脾切除术(135例OS和81例LS)。5例腹腔镜手术因术中出血或脾窝出血转为开放手术。其他76例患者成功实施了LS。未发生重大手术并发症。无手术死亡。本系列中56%的病例切除脾脏重量>400g。术后7天,开放手术和腹腔镜手术后血小板计数、白细胞计数及血红蛋白均显著升高,且LS组谷丙转氨酶、谷草转氨酶、总胆红素及直接胆红素的升高与开放手术病例有显著差异。LS和OS的手术时间分别为2.9±0.7小时和2.6±0.6小时。失血量分别为150.6±135.4ml和633.8±340.3ml(P<0.01),切除脾脏重量分别为585.7±184.6g和591.1±153.4g(P>0.05),住院时间分别为8.2±2.0天和11.9±3.8天(P<0.01)。LS和OS均有手术相关并发症。与OS相比,LS失血量更少、住院时间更短且肝功能损害更小。
LS对于肝硬化继发的脾功能亢进是可行、有效且安全的手术方式,有助于减少肝功能损害、减少失血量及缩短住院时间。